Search details
1.
Transitioning Long-Acting Products to a Generic Marketplace: What's Missing?
Clin Infect Dis
; 75(Suppl 4): S557-S561, 2022 11 21.
Article
in English
| MEDLINE | ID: mdl-36410379
2.
Ending AIDS as a public health threat by 2030: Time to reset targets for 2025.
PLoS Med
; 18(6): e1003649, 2021 06.
Article
in English
| MEDLINE | ID: mdl-34101728
3.
Cost-effectiveness of intervention combinations towards the elimination of vertical transmission of HIV in limited-resource settings: a mathematical modelling study.
Lancet Glob Health
; 12(3): e457-e466, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38365416
4.
Securing accelerated access to long-acting injectable cabotegravir for HIV prevention in low- and middle-income countries.
J Int AIDS Soc
; 26 Suppl 2: e26101, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37439082
5.
High acceptability and viral suppression rate for first-Line patients on a dolutegravir-based regimen: An early adopter study in Nigeria.
PLoS One
; 18(5): e0284767, 2023.
Article
in English
| MEDLINE | ID: mdl-37196012
6.
A Model for Accelerating Access to Care and Treatment for Children and Adolescents Living with HIV in Nigeria, Tanzania, Uganda, and Zambia: The Faith-Based Action for Scaling-Up Testing and Treatment for the Epidemic Response (FASTER) Initiative.
J Int Assoc Provid AIDS Care
; 22: 23259582231186701, 2023.
Article
in English
| MEDLINE | ID: mdl-37499208
7.
Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study.
Lancet HIV
; 10(4): e254-e265, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36642087
8.
Accelerating access and scale-up of optimized antiretroviral therapy in low-income and middle-income countries: results of a coordinated end-to-end approach.
AIDS
; 35(Suppl 2): S165-S171, 2021 12 15.
Article
in English
| MEDLINE | ID: mdl-34848583
9.
One Step Closer to Ending AIDS in Children.
Pediatr Infect Dis J
; 42(7): 582-583, 2023 Jul 01.
Article
in English
| MEDLINE | ID: mdl-37200515
10.
Can the generic antiretroviral industry support access to a universal antiretroviral regimen?
Curr Opin HIV AIDS
; 12(4): 390-397, 2017 Jul.
Article
in English
| MEDLINE | ID: mdl-28441147
11.
Optimizing antiretroviral product selection: a sample approach to improving patient outcomes, saving money, and scaling-up health services in developing countries.
J Acquir Immune Defic Syndr
; 57 Suppl 2: S100-3, 2011 Aug.
Article
in English
| MEDLINE | ID: mdl-21857290
Results
1 -
11
de 11
1
Next >
>>